MGMT Methylation and Glioma Jun 29, 2018 A DNA-level biomarker may be helpful in predicting survival outcomes in patients with high-risk, low-grade gliomas, a new study suggests. The NRG Oncology/ Radiation Therapy Oncology Group (RTOG) collaborative clinical trials group reports that MGMT promoter methylation has the potential to be used as an independent prognostic biomarker in World…
Failure to Diagnose Cancer Failure to diagnose cancer is a legal term used to describe an incident where a medical professional fails to identify and treat cancer in a patient. Failure to diagnose typically indicates that the patient exhibited visible cancer signs and symptoms, and therefore a cancer diagnosis should have been made. For many…
Medical Errors in Cancer Medical errors have been defined as “the failure of a planned action to be completed as intended or the use of a wrong plan to achieve an aim.” Harmful medical errors are adverse events caused by medical errors. Attention to medical error has increased in recent years in medicine and oncology,…